JP2013534233A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013534233A5 JP2013534233A5 JP2013524421A JP2013524421A JP2013534233A5 JP 2013534233 A5 JP2013534233 A5 JP 2013534233A5 JP 2013524421 A JP2013524421 A JP 2013524421A JP 2013524421 A JP2013524421 A JP 2013524421A JP 2013534233 A5 JP2013534233 A5 JP 2013534233A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazolo
- methyl
- pyrazol
- pyrimidin
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 30
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 26
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 19
- 229910052736 halogen Inorganic materials 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 13
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 150000002367 halogens Chemical class 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- -1 heterocyclyl compound Chemical class 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- UQPXYEYBUROSJF-UHFFFAOYSA-N 1,6-diazaspiro[3.3]heptane Chemical compound N1CCC11CNC1 UQPXYEYBUROSJF-UHFFFAOYSA-N 0.000 claims 1
- WIAQVEOZEVXBLK-UHFFFAOYSA-N 1-(dimethylamino)-3-[4-[[1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]propan-2-ol Chemical compound C1=NN(CC(O)CN(C)C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 WIAQVEOZEVXBLK-UHFFFAOYSA-N 0.000 claims 1
- AIPWKMARVVQHIZ-UHFFFAOYSA-N 1-[(2,3-difluoro-5-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3CCOCC3)F)C2=N1 AIPWKMARVVQHIZ-UHFFFAOYSA-N 0.000 claims 1
- IOHPHOVOIWXLOQ-UHFFFAOYSA-N 1-[(2,3-difluoro-5-piperazin-1-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3CCNCC3)F)C2=N1 IOHPHOVOIWXLOQ-UHFFFAOYSA-N 0.000 claims 1
- ZEGGSAUHKBOSRB-UHFFFAOYSA-N 1-[(2,5-difluoro-3-piperazin-1-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCNCC4)C=C(F)C=3)F)C2=N1 ZEGGSAUHKBOSRB-UHFFFAOYSA-N 0.000 claims 1
- IBJINTQEVNSIPA-UHFFFAOYSA-N 1-[(2,6-difluoro-3-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=CC=3F)F)C2=N1 IBJINTQEVNSIPA-UHFFFAOYSA-N 0.000 claims 1
- YFDUXROIWMDICD-UHFFFAOYSA-N 1-[(2-chloro-3-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=CC=3)Cl)C2=N1 YFDUXROIWMDICD-UHFFFAOYSA-N 0.000 claims 1
- TTXQDRDDHYSWCG-UHFFFAOYSA-N 1-[(2-fluoro-3-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=CC=3)F)C2=N1 TTXQDRDDHYSWCG-UHFFFAOYSA-N 0.000 claims 1
- LCLFUUUFFSKKRQ-UHFFFAOYSA-N 1-[(2-fluoro-3-piperazin-1-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCNCC4)C=CC=3)F)C2=N1 LCLFUUUFFSKKRQ-UHFFFAOYSA-N 0.000 claims 1
- DXJLNSJZOYPILI-UHFFFAOYSA-N 1-[(2-fluoro-5-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=CC=C(C=3)N3CCOCC3)F)C2=N1 DXJLNSJZOYPILI-UHFFFAOYSA-N 0.000 claims 1
- XPNKQYYVMWJGIP-UHFFFAOYSA-N 1-[(2-methyl-3-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=CC=C(N2CCOCC2)C(C)=C1CN(C1=N2)N=CC1=CN=C2NC=1C=NN(C)C=1 XPNKQYYVMWJGIP-UHFFFAOYSA-N 0.000 claims 1
- UTOMTFZIGBUZJC-UHFFFAOYSA-N 1-[(3-fluoro-5-morpholin-4-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3CCOCC3)C2=N1 UTOMTFZIGBUZJC-UHFFFAOYSA-N 0.000 claims 1
- AFJQMCYSUWEOLJ-UHFFFAOYSA-N 1-[(3-fluoro-5-piperazin-1-ylphenyl)methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3CCNCC3)C2=N1 AFJQMCYSUWEOLJ-UHFFFAOYSA-N 0.000 claims 1
- KQFDSKUATBKDQT-UHFFFAOYSA-N 1-[(3-morpholin-4-ylphenyl)methyl]-n-[1-(piperidin-3-ylmethyl)pyrazol-4-yl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=C(NC=2N=C3N(CC=4C=C(C=CC=4)N4CCOCC4)N=CC3=CN=2)C=NN1CC1CCCNC1 KQFDSKUATBKDQT-UHFFFAOYSA-N 0.000 claims 1
- JMLXWLDQGXMEHE-UHFFFAOYSA-N 1-[(3-morpholin-4-ylphenyl)methyl]-n-[1-(pyrrolidin-3-ylmethyl)pyrazol-4-yl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=C(NC=2N=C3N(CC=4C=C(C=CC=4)N4CCOCC4)N=CC3=CN=2)C=NN1CC1CCNC1 JMLXWLDQGXMEHE-UHFFFAOYSA-N 0.000 claims 1
- QJIWPIMERUHTCJ-UHFFFAOYSA-N 1-[2,4-difluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(CNCC4)=O)C=CC=3F)F)C2=N1 QJIWPIMERUHTCJ-UHFFFAOYSA-N 0.000 claims 1
- WXELJEBIOJRVCJ-UHFFFAOYSA-N 1-[2-fluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(CNCC4)=O)C=CC=3)F)C2=N1 WXELJEBIOJRVCJ-UHFFFAOYSA-N 0.000 claims 1
- BTVOZQZBAOSNOE-UHFFFAOYSA-N 1-[2-fluoro-3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(CNCC4)=O)C=CC=3)F)C2=N1 BTVOZQZBAOSNOE-UHFFFAOYSA-N 0.000 claims 1
- JQUASVYSBGGPMN-UHFFFAOYSA-N 1-[3,4-difluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3C(CNCC3)=O)F)C2=N1 JQUASVYSBGGPMN-UHFFFAOYSA-N 0.000 claims 1
- RDBOBWQYTXNMOO-UHFFFAOYSA-N 1-[3,4-difluoro-5-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3C(CNCC3)=O)F)C2=N1 RDBOBWQYTXNMOO-UHFFFAOYSA-N 0.000 claims 1
- SPYBDNGMYOLKKT-UHFFFAOYSA-N 1-[3-[4-[[1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]propyl]pyrrolidin-2-one Chemical compound O=C1CCCN1CCCN1N=CC(NC=2N=C3N(CC=4C=C(C=CC=4)N4CCOCC4)N=CC3=CN=2)=C1 SPYBDNGMYOLKKT-UHFFFAOYSA-N 0.000 claims 1
- BNTKLVFPGMSLPS-UHFFFAOYSA-N 1-[3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3C(CNCC3)=O)C2=N1 BNTKLVFPGMSLPS-UHFFFAOYSA-N 0.000 claims 1
- AZMWRRAPMUJHLW-UHFFFAOYSA-N 1-[3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperidin-4-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCC(=O)CC3)C2=N1 AZMWRRAPMUJHLW-UHFFFAOYSA-N 0.000 claims 1
- WRQWPHAULJEKEJ-UHFFFAOYSA-N 1-[3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3C(CNCC3)=O)C2=N1 WRQWPHAULJEKEJ-UHFFFAOYSA-N 0.000 claims 1
- HLHPEQUSUXNOGX-UHFFFAOYSA-N 1-[3-fluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(CNCC3)=O)C2=N1 HLHPEQUSUXNOGX-UHFFFAOYSA-N 0.000 claims 1
- RQAUXJQYPZFDHH-UHFFFAOYSA-N 1-[3-fluoro-5-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]piperazin-2-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(CNCC3)=O)C2=N1 RQAUXJQYPZFDHH-UHFFFAOYSA-N 0.000 claims 1
- OJFIRFVBSDGLRA-UHFFFAOYSA-N 1-[[2-fluoro-3-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CC5(COC5)C4)C=CC=3)F)C2=N1 OJFIRFVBSDGLRA-UHFFFAOYSA-N 0.000 claims 1
- WFJVTASXQBMCIJ-UHFFFAOYSA-N 1-[[3-(1,1-dioxo-1,4-thiazinan-4-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCS(=O)(=O)CC3)C2=N1 WFJVTASXQBMCIJ-UHFFFAOYSA-N 0.000 claims 1
- DLEKHBZBTGJFAS-UHFFFAOYSA-N 1-[[3-(3-methoxyazetidin-1-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1C(OC)CN1C1=CC=CC(CN2C3=NC(NC4=CN(C)N=C4)=NC=C3C=N2)=C1 DLEKHBZBTGJFAS-UHFFFAOYSA-N 0.000 claims 1
- DLTRTXBWIQHSTB-UHFFFAOYSA-N 1-[[3-(4,4-difluoropiperidin-1-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical class C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCC(F)(F)CC3)C2=N1 DLTRTXBWIQHSTB-UHFFFAOYSA-N 0.000 claims 1
- FSMNQKHHJYPTFO-UHFFFAOYSA-N 1-[[3-(4-methoxypiperidin-1-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1CC(OC)CCN1C1=CC=CC(CN2C3=NC(NC4=CN(C)N=C4)=NC=C3C=N2)=C1 FSMNQKHHJYPTFO-UHFFFAOYSA-N 0.000 claims 1
- UEBQTSPICQTRGC-UHFFFAOYSA-N 1-[[3-(4-methylpiperazin-1-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1CN(C)CCN1C1=CC=CC(CN2C3=NC(NC4=CN(C)N=C4)=NC=C3C=N2)=C1 UEBQTSPICQTRGC-UHFFFAOYSA-N 0.000 claims 1
- AJOWICGTADKWML-OAHLLOKOSA-N 1-[[3-[(3r)-3-methylmorpholin-4-yl]phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C[C@@H]1COCCN1C1=CC=CC(CN2C3=NC(NC4=CN(C)N=C4)=NC=C3C=N2)=C1 AJOWICGTADKWML-OAHLLOKOSA-N 0.000 claims 1
- AJOWICGTADKWML-HNNXBMFYSA-N 1-[[3-[(3s)-3-methylmorpholin-4-yl]phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C[C@H]1COCCN1C1=CC=CC(CN2C3=NC(NC4=CN(C)N=C4)=NC=C3C=N2)=C1 AJOWICGTADKWML-HNNXBMFYSA-N 0.000 claims 1
- NKSBPJOOITYGIE-UHFFFAOYSA-N 1-[[3-fluoro-5-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3CC4(COC4)C3)C2=N1 NKSBPJOOITYGIE-UHFFFAOYSA-N 0.000 claims 1
- GFQVJTJYTXUIJL-CQSZACIVSA-N 1-[[6-[(3r)-3-methylmorpholin-4-yl]pyridin-2-yl]methyl]-n-(1-methylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C[C@@H]1COCCN1C1=CC=CC(CN2C3=NC(NC4=CN(C)N=C4)=NC=C3C=N2)=N1 GFQVJTJYTXUIJL-CQSZACIVSA-N 0.000 claims 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims 1
- KVSYZIDXSXHKCJ-UHFFFAOYSA-N 2-[4-(1h-pyrazolo[3,4-d]pyrimidin-6-ylamino)pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2)C2=N1 KVSYZIDXSXHKCJ-UHFFFAOYSA-N 0.000 claims 1
- JKNQFZHGPWIFAG-UHFFFAOYSA-N 2-[4-[[1-[(2,3,6-trifluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=C(F)C=3F)F)C2=N1 JKNQFZHGPWIFAG-UHFFFAOYSA-N 0.000 claims 1
- IDHAVUSUUCAQSL-UHFFFAOYSA-N 2-[4-[[1-[(2,3-difluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3CCOCC3)F)C2=N1 IDHAVUSUUCAQSL-UHFFFAOYSA-N 0.000 claims 1
- PLMVRZSABYUHTI-UHFFFAOYSA-N 2-[4-[[1-[(2,3-difluoro-5-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3CCNCC3)F)C2=N1 PLMVRZSABYUHTI-UHFFFAOYSA-N 0.000 claims 1
- JCKFUFCNHPKBBX-UHFFFAOYSA-N 2-[4-[[1-[(2,5-difluoro-3-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCNCC4)C=C(F)C=3)F)C2=N1 JCKFUFCNHPKBBX-UHFFFAOYSA-N 0.000 claims 1
- LBZVZBGLGGAFIE-UHFFFAOYSA-N 2-[4-[[1-[(2,6-difluoro-3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=CC=3F)F)C2=N1 LBZVZBGLGGAFIE-UHFFFAOYSA-N 0.000 claims 1
- XVEQQWBZJQGFSC-UHFFFAOYSA-N 2-[4-[[1-[(2-fluoro-3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=CC=3)F)C2=N1 XVEQQWBZJQGFSC-UHFFFAOYSA-N 0.000 claims 1
- ZGAOSRYKXSUHCS-UHFFFAOYSA-N 2-[4-[[1-[(2-fluoro-3-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCNCC4)C=CC=3)F)C2=N1 ZGAOSRYKXSUHCS-UHFFFAOYSA-N 0.000 claims 1
- AMLWWPHPIOSFIP-UHFFFAOYSA-N 2-[4-[[1-[(2-fluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=CC=C(C=3)N3CCOCC3)F)C2=N1 AMLWWPHPIOSFIP-UHFFFAOYSA-N 0.000 claims 1
- IVFMRWYEJNNOSL-UHFFFAOYSA-N 2-[4-[[1-[(3-fluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3CCOCC3)C2=N1 IVFMRWYEJNNOSL-UHFFFAOYSA-N 0.000 claims 1
- JRBOTIHEEGZUOK-UHFFFAOYSA-N 2-[4-[[1-[(3-fluoro-5-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3CCNCC3)C2=N1 JRBOTIHEEGZUOK-UHFFFAOYSA-N 0.000 claims 1
- ADHYCGHWYPLLIU-UHFFFAOYSA-N 2-[4-[[1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 ADHYCGHWYPLLIU-UHFFFAOYSA-N 0.000 claims 1
- NWJHQZYVBOJLSD-UHFFFAOYSA-N 2-[4-[[1-[(3-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCNCC3)C2=N1 NWJHQZYVBOJLSD-UHFFFAOYSA-N 0.000 claims 1
- UCTKCNCLAKUTBN-UHFFFAOYSA-N 2-[4-[[1-[[3-fluoro-5-(3-oxomorpholin-4-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]-n-methylacetamide Chemical compound C1=NN(CC(=O)NC)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(COCC3)=O)C2=N1 UCTKCNCLAKUTBN-UHFFFAOYSA-N 0.000 claims 1
- HPJALMWOZYIZGE-UHFFFAOYSA-N 2-oxa-6-azaspiro[3.3]heptane Chemical compound C1NCC11COC1 HPJALMWOZYIZGE-UHFFFAOYSA-N 0.000 claims 1
- ZHAIMJRKJKQNQI-UHFFFAOYSA-N 2-oxa-7-azaspiro[3.4]octane Chemical compound C1OCC11CNCC1 ZHAIMJRKJKQNQI-UHFFFAOYSA-N 0.000 claims 1
- HHCUDGFSZCPXBA-UHFFFAOYSA-N 3-[4-[[1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]-1-piperidin-1-ylpropan-1-one Chemical compound C1CCCCN1C(=O)CCN(N=C1)C=C1NC(N=C12)=NC=C1C=NN2CC(C=1)=CC=CC=1N1CCOCC1 HHCUDGFSZCPXBA-UHFFFAOYSA-N 0.000 claims 1
- UECOHTOIDJMHEA-UHFFFAOYSA-N 3-[4-[[1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]propan-1-ol Chemical compound C1=NN(CCCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 UECOHTOIDJMHEA-UHFFFAOYSA-N 0.000 claims 1
- LVTIWPSUJMJESA-UHFFFAOYSA-N 3-[4-[[1-[[3-fluoro-5-(3-oxomorpholin-4-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]pyrazol-1-yl]propanenitrile Chemical compound C=1C(N2C(COCC2)=O)=CC(F)=CC=1CN(C1=N2)N=CC1=CN=C2NC=1C=NN(CCC#N)C=1 LVTIWPSUJMJESA-UHFFFAOYSA-N 0.000 claims 1
- YIEBDLBEOOYPKH-UHFFFAOYSA-N 4-[2,4,5-trifluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=C(F)C=3F)F)C2=N1 YIEBDLBEOOYPKH-UHFFFAOYSA-N 0.000 claims 1
- SQQIBUDXKLMRIC-UHFFFAOYSA-N 4-[2,4,5-trifluoro-3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=C(F)C=3F)F)C2=N1 SQQIBUDXKLMRIC-UHFFFAOYSA-N 0.000 claims 1
- XCDSNHMNFAMFPE-UHFFFAOYSA-N 4-[2,4-difluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=CC=3F)F)C2=N1 XCDSNHMNFAMFPE-UHFFFAOYSA-N 0.000 claims 1
- ZROFCNQKUJJWCC-UHFFFAOYSA-N 4-[2,5-difluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=C(F)C=3)F)C2=N1 ZROFCNQKUJJWCC-UHFFFAOYSA-N 0.000 claims 1
- WERGRTLMDCAJBN-UHFFFAOYSA-N 4-[2,5-difluoro-3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=C(F)C=3)F)C2=N1 WERGRTLMDCAJBN-UHFFFAOYSA-N 0.000 claims 1
- XEOGUJOFCRKSLS-UHFFFAOYSA-N 4-[2-fluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=CC=3)F)C2=N1 XEOGUJOFCRKSLS-UHFFFAOYSA-N 0.000 claims 1
- AKPINERRIDHKNA-UHFFFAOYSA-N 4-[2-fluoro-3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=CC=3)F)C2=N1 AKPINERRIDHKNA-UHFFFAOYSA-N 0.000 claims 1
- KCEAFICRYYALLL-UHFFFAOYSA-N 4-[3,4-difluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3C(COCC3)=O)F)C2=N1 KCEAFICRYYALLL-UHFFFAOYSA-N 0.000 claims 1
- PUTTZUSRYCVDCO-UHFFFAOYSA-N 4-[3,4-difluoro-5-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)N3C(COCC3)=O)F)C2=N1 PUTTZUSRYCVDCO-UHFFFAOYSA-N 0.000 claims 1
- ZVLOCMSXMRKPDV-UHFFFAOYSA-N 4-[3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3C(COCC3)=O)C2=N1 ZVLOCMSXMRKPDV-UHFFFAOYSA-N 0.000 claims 1
- MJHNNNYIOSCRRS-UHFFFAOYSA-N 4-[3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3C(COCC3)=O)C2=N1 MJHNNNYIOSCRRS-UHFFFAOYSA-N 0.000 claims 1
- VWYIHOLKSKHXAY-UHFFFAOYSA-N 4-[3-[[6-[[1-[3-(dimethylamino)-2-fluoropropyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-5-fluorophenyl]morpholin-3-one Chemical compound C1=NN(CC(F)CN(C)C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(COCC3)=O)C2=N1 VWYIHOLKSKHXAY-UHFFFAOYSA-N 0.000 claims 1
- TVLQJWFNXHUASP-UHFFFAOYSA-N 4-[3-[[6-[[1-[3-(dimethylamino)propyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-2,4,5-trifluorophenyl]morpholin-3-one Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=C(F)C=3F)F)C2=N1 TVLQJWFNXHUASP-UHFFFAOYSA-N 0.000 claims 1
- OKLNKDRRWXNPTA-UHFFFAOYSA-N 4-[3-[[6-[[1-[3-(dimethylamino)propyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-2,4-difluorophenyl]morpholin-3-one Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=CC=3F)F)C2=N1 OKLNKDRRWXNPTA-UHFFFAOYSA-N 0.000 claims 1
- NOQKEMDAFGKGIP-UHFFFAOYSA-N 4-[3-[[6-[[1-[3-(dimethylamino)propyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-2-fluorophenyl]morpholin-3-one Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4C(COCC4)=O)C=CC=3)F)C2=N1 NOQKEMDAFGKGIP-UHFFFAOYSA-N 0.000 claims 1
- YBSCBTKKTJIFHR-UHFFFAOYSA-N 4-[3-[[6-[[1-[3-(dimethylamino)propyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3C(COCC3)=O)C2=N1 YBSCBTKKTJIFHR-UHFFFAOYSA-N 0.000 claims 1
- OXCYMZXAQOUWAF-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(COCC3)=O)C2=N1 OXCYMZXAQOUWAF-UHFFFAOYSA-N 0.000 claims 1
- YZOROCGBWSXAJE-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C=1C(N2C(COCC2)=O)=CC(F)=CC=1CN(C1=N2)N=CC1=CN=C2NC(=C1)C=NN1C1CCNCC1 YZOROCGBWSXAJE-UHFFFAOYSA-N 0.000 claims 1
- QQLJVKJBYFKING-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(COCC3)=O)C2=N1 QQLJVKJBYFKING-UHFFFAOYSA-N 0.000 claims 1
- VHACRAPXUPIGOS-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[[1-(2-oxo-2-piperazin-1-ylethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C=1C(N2C(COCC2)=O)=CC(F)=CC=1CN(C1=N2)N=CC1=CN=C2NC(=C1)C=NN1CC(=O)N1CCNCC1 VHACRAPXUPIGOS-UHFFFAOYSA-N 0.000 claims 1
- YQKNIWKEFSQCEA-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[[1-(pyrrolidin-3-ylmethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C=1C(N2C(COCC2)=O)=CC(F)=CC=1CN(C1=N2)N=CC1=CN=C2NC(=C1)C=NN1CC1CCNC1 YQKNIWKEFSQCEA-UHFFFAOYSA-N 0.000 claims 1
- DUSOICYKBHNXEL-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[[1-[(5-oxopyrrolidin-3-yl)methyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C=1C(N2C(COCC2)=O)=CC(F)=CC=1CN(C1=N2)N=CC1=CN=C2NC(=C1)C=NN1CC1CNC(=O)C1 DUSOICYKBHNXEL-UHFFFAOYSA-N 0.000 claims 1
- CRRWFEMDYQRYCD-UHFFFAOYSA-N 4-[3-fluoro-5-[[6-[[1-[3-(methylamino)propyl]pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]morpholin-3-one Chemical compound C1=NN(CCCNC)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)N3C(COCC3)=O)C2=N1 CRRWFEMDYQRYCD-UHFFFAOYSA-N 0.000 claims 1
- POOPWPIOIMBTOH-UHFFFAOYSA-N 8-oxa-3-azabicyclo[3.2.1]octane Chemical compound C1NCC2CCC1O2 POOPWPIOIMBTOH-UHFFFAOYSA-N 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- AJQHWAKMGMTSIQ-UHFFFAOYSA-N [2-fluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]-morpholin-4-ylmethanone Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(C(=O)N4CCOCC4)C=CC=3)F)C2=N1 AJQHWAKMGMTSIQ-UHFFFAOYSA-N 0.000 claims 1
- UXGFHFOLYDAKIY-UHFFFAOYSA-N [2-fluoro-3-[[6-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]-morpholin-4-ylmethanone Chemical compound C1=NN(CCO)C=C1NC1=NC=C(C=NN2CC=3C(=C(C(=O)N4CCOCC4)C=CC=3)F)C2=N1 UXGFHFOLYDAKIY-UHFFFAOYSA-N 0.000 claims 1
- QIKSIJWWAXRKHR-UHFFFAOYSA-N [3,4-difluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]-morpholin-4-ylmethanone Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(F)C=C(C=3)C(=O)N3CCOCC3)F)C2=N1 QIKSIJWWAXRKHR-UHFFFAOYSA-N 0.000 claims 1
- WHWXPCVUBTVRMO-UHFFFAOYSA-N [3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]-morpholin-4-ylmethanone Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)C(=O)N3CCOCC3)C2=N1 WHWXPCVUBTVRMO-UHFFFAOYSA-N 0.000 claims 1
- BFYISBMBJISDLJ-UHFFFAOYSA-N [3-fluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]-morpholin-4-ylmethanone Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)C(=O)N3CCOCC3)C2=N1 BFYISBMBJISDLJ-UHFFFAOYSA-N 0.000 claims 1
- BOHCVAPFQDXESM-UHFFFAOYSA-N [3-fluoro-5-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]-piperazin-1-ylmethanone Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=C(F)C=3)C(=O)N3CCNCC3)C2=N1 BOHCVAPFQDXESM-UHFFFAOYSA-N 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims 1
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- VSEAAEQOQBMPQF-UHFFFAOYSA-N morpholin-3-one Chemical compound O=C1COCCN1 VSEAAEQOQBMPQF-UHFFFAOYSA-N 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- OPVOONBHXINVKC-UHFFFAOYSA-N morpholin-4-yl-[2,4,5-trifluoro-3-[[6-[(1-methylpyrazol-4-yl)amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]phenyl]methanone Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(C(=O)N4CCOCC4)C=C(F)C=3F)F)C2=N1 OPVOONBHXINVKC-UHFFFAOYSA-N 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- DIUJLEHOODQLHY-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[(2,3,6-trifluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=C(F)C=3F)F)C2=N1 DIUJLEHOODQLHY-UHFFFAOYSA-N 0.000 claims 1
- JWGDKIZETGKOOA-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[(2,3,6-trifluoro-5-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCNCC4)C=C(F)C=3F)F)C2=N1 JWGDKIZETGKOOA-UHFFFAOYSA-N 0.000 claims 1
- NNRNNWAFTKYION-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 NNRNNWAFTKYION-UHFFFAOYSA-N 0.000 claims 1
- QZWIWFGLEPZWCL-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[(3-piperazin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCNCC3)C2=N1 QZWIWFGLEPZWCL-UHFFFAOYSA-N 0.000 claims 1
- LPZIDGODUFMKSW-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[(3-piperidin-1-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCCCC3)C2=N1 LPZIDGODUFMKSW-UHFFFAOYSA-N 0.000 claims 1
- UUVCPFMSHZOVOK-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[(6-morpholin-4-ylpyridin-2-yl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3N=C(C=CC=3)N3CCOCC3)C2=N1 UUVCPFMSHZOVOK-UHFFFAOYSA-N 0.000 claims 1
- KXQJIGNZDJSTKF-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CC4(COC4)C3)C2=N1 KXQJIGNZDJSTKF-UHFFFAOYSA-N 0.000 claims 1
- SPDXJWNWFUSXMG-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(2-oxa-7-azaspiro[3.4]octan-7-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CC4(COC4)CC3)C2=N1 SPDXJWNWFUSXMG-UHFFFAOYSA-N 0.000 claims 1
- YBGKKCOPRBYAAZ-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(4-methylsulfonylpiperazin-1-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCN(CC3)S(C)(=O)=O)C2=N1 YBGKKCOPRBYAAZ-UHFFFAOYSA-N 0.000 claims 1
- XFWXERCRRYGSOY-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CC4CCC(O4)C3)C2=N1 XFWXERCRRYGSOY-UHFFFAOYSA-N 0.000 claims 1
- OSELICAWOINZKR-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(morpholin-4-ylmethyl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(CN4CCOCC4)C=CC=3)C2=N1 OSELICAWOINZKR-UHFFFAOYSA-N 0.000 claims 1
- KAVSGWIDFBJIDL-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(oxan-4-yl)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)C3CCOCC3)C2=N1 KAVSGWIDFBJIDL-UHFFFAOYSA-N 0.000 claims 1
- AJYRPZYDWPZPSX-UHFFFAOYSA-N n-(1-methylpyrazol-4-yl)-1-[[3-(oxetan-3-ylamino)phenyl]methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(C)C=C1NC1=NC=C(C=NN2CC=3C=C(NC4COC4)C=CC=3)C2=N1 AJYRPZYDWPZPSX-UHFFFAOYSA-N 0.000 claims 1
- WQIPBIRAHKZDDD-UHFFFAOYSA-N n-(1h-pyrazol-4-yl)-1-[(2,3,6-trifluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound FC=1C(CN2C3=NC(NC4=CNN=C4)=NC=C3C=N2)=C(F)C(F)=CC=1N1CCOCC1 WQIPBIRAHKZDDD-UHFFFAOYSA-N 0.000 claims 1
- VGLSHXRZKTWKBX-UHFFFAOYSA-N n-[1-(2,2-difluoroethyl)pyrazol-4-yl]-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(CC(F)F)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 VGLSHXRZKTWKBX-UHFFFAOYSA-N 0.000 claims 1
- TZKSLWHYQMWGAH-UHFFFAOYSA-N n-[1-(3-aminopropyl)pyrazol-4-yl]-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(CCCN)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 TZKSLWHYQMWGAH-UHFFFAOYSA-N 0.000 claims 1
- KPNNIUGCCUHQCN-UHFFFAOYSA-N n-[1-(pyrrolidin-3-ylmethyl)pyrazol-4-yl]-1-[(2,3,6-trifluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound FC=1C(CN2C3=NC(NC4=CN(CC5CNCC5)N=C4)=NC=C3C=N2)=C(F)C(F)=CC=1N1CCOCC1 KPNNIUGCCUHQCN-UHFFFAOYSA-N 0.000 claims 1
- COLAKVWAWPDBMW-UHFFFAOYSA-N n-[1-[3-(dimethylamino)-2-methylpropyl]pyrazol-4-yl]-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(CC(CN(C)C)C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 COLAKVWAWPDBMW-UHFFFAOYSA-N 0.000 claims 1
- YQXJKGGMDCZQLK-UHFFFAOYSA-N n-[1-[3-(dimethylamino)propyl]pyrazol-4-yl]-1-[(2,3,6-trifluoro-5-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=C(F)C=3F)F)C2=N1 YQXJKGGMDCZQLK-UHFFFAOYSA-N 0.000 claims 1
- NEJZGXMTHYMCPI-UHFFFAOYSA-N n-[1-[3-(dimethylamino)propyl]pyrazol-4-yl]-1-[(2-fluoro-3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C(=C(N4CCOCC4)C=CC=3)F)C2=N1 NEJZGXMTHYMCPI-UHFFFAOYSA-N 0.000 claims 1
- GYHRXXSXXJCFMH-UHFFFAOYSA-N n-[1-[3-(dimethylamino)propyl]pyrazol-4-yl]-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=NN(CCCN(C)C)C=C1NC1=NC=C(C=NN2CC=3C=C(C=CC=3)N3CCOCC3)C2=N1 GYHRXXSXXJCFMH-UHFFFAOYSA-N 0.000 claims 1
- KCJAMOQUNKKAOD-UHFFFAOYSA-N n-[1-[[3-(methylaminomethyl)oxetan-3-yl]methyl]pyrazol-4-yl]-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=C(NC=2N=C3N(CC=4C=C(C=CC=4)N4CCOCC4)N=CC3=CN=2)C=NN1CC1(CNC)COC1 KCJAMOQUNKKAOD-UHFFFAOYSA-N 0.000 claims 1
- UVEHOWWEAQITEG-UHFFFAOYSA-N n-[1-[[3-[(dimethylamino)methyl]oxetan-3-yl]methyl]pyrazol-4-yl]-1-[(3-morpholin-4-ylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound C1=C(NC=2N=C3N(CC=4C=C(C=CC=4)N4CCOCC4)N=CC3=CN=2)C=NN1CC1(CN(C)C)COC1 UVEHOWWEAQITEG-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37535810P | 2010-08-20 | 2010-08-20 | |
| US61/375,358 | 2010-08-20 | ||
| PCT/EP2010/065700 WO2011048082A1 (en) | 2009-10-20 | 2010-10-19 | Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
| EPPCT/EP2010/065700 | 2010-10-19 | ||
| US201161476398P | 2011-04-18 | 2011-04-18 | |
| US61/476,398 | 2011-04-18 | ||
| PCT/EP2011/063905 WO2012022681A2 (en) | 2010-08-20 | 2011-08-12 | Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013534233A JP2013534233A (ja) | 2013-09-02 |
| JP2013534233A5 true JP2013534233A5 (https=) | 2014-10-30 |
Family
ID=44630379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524421A Pending JP2013534233A (ja) | 2010-08-20 | 2011-08-12 | 選択的ｊａｋ阻害剤としてのヘテロシクリルピラゾロピリミジン類似体 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US9040545B2 (https=) |
| JP (1) | JP2013534233A (https=) |
| WO (1) | WO2012022681A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013041605A1 (en) | 2011-09-20 | 2013-03-28 | Cellzome Limited | Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors |
| CN104169272A (zh) | 2011-12-23 | 2014-11-26 | 赛尔佐姆有限公司 | 作为激酶抑制剂的嘧啶-2,4-二胺衍生物 |
| WO2014090700A1 (en) | 2012-12-14 | 2014-06-19 | Basf Se | Malononitrile compounds for controlling animal pests |
| AR099134A1 (es) * | 2014-01-24 | 2016-06-29 | Hoffmann La Roche | Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina |
| EP3131398B1 (en) | 2014-04-17 | 2019-10-23 | Boehringer Ingelheim Animal Health USA Inc. | Use of malononitrile compounds for protecting animals from parasites |
| NO2721710T3 (https=) | 2014-08-21 | 2018-03-31 | ||
| HUE059242T2 (hu) * | 2016-07-29 | 2022-11-28 | Rapt Therapeutics Inc | Azetidin-származékok mint kemokin receptor modulátorok és felhasználásuk |
| CN110885331B (zh) * | 2018-09-11 | 2021-07-09 | 中国药科大学 | 一种6-氨基-1H-吡唑并[3，4-d]嘧啶类JAK激酶抑制剂的制备与应用 |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| TWI899080B (zh) * | 2019-05-27 | 2025-10-01 | 大陸商迪哲（江蘇）醫藥股份有限公司 | Ｄｎａ依賴性蛋白激酶抑制劑 |
| WO2021048736A1 (en) | 2019-09-11 | 2021-03-18 | Pfizer Inc. | Treatment of hidradenitis with jak inhibitors |
| JP2025509615A (ja) * | 2022-03-17 | 2025-04-11 | ファイザー・インコーポレイテッド | 汗腺炎を治療するための方法、投与計画、および組成物 |
| WO2025235331A1 (en) * | 2024-05-07 | 2025-11-13 | Nikang Therapeutics, Inc. | Bifunctional compounds containing pyrazolopyrimidine derivatives for degrading certain cyclin-dependent kinase via ubiquitin proteasome pathway |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69837529T2 (de) | 1997-02-12 | 2007-07-26 | Electrophoretics Ltd., Cobham | Proteinmarker für lungenkrebs und deren verwendung |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| SK288365B6 (sk) | 1999-02-10 | 2016-07-01 | Astrazeneca Ab | Medziprodukty pre chinazolínové deriváty ako inhibítory angiogenézy |
| CZ301689B6 (cs) | 1999-11-05 | 2010-05-26 | Astrazeneca Ab | Derivát chinazolinu a farmaceutický prostredek, který ho obsahuje |
| EP1382339B1 (en) | 1999-12-10 | 2007-12-05 | Pfizer Products Inc. | Compositions containing pyrrolo ¬2,3-d pyrimidine derivatives |
| SI1255752T1 (sl) | 2000-02-15 | 2007-12-31 | Pharmacia & Upjohn Co Llc | S pirolom substituirani zaviralci 2-indolinon protein kinaza |
| EP1846408B1 (en) | 2005-01-14 | 2013-03-20 | Janssen Pharmaceutica NV | 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| PL1891446T3 (pl) | 2005-06-14 | 2013-08-30 | Cellzome Gmbh | Sposób identyfikacji nowych związków oddziałujących z enzymami |
| GB0605691D0 (en) | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic Compounds |
| EP1862802B1 (en) | 2006-06-01 | 2008-12-10 | Cellzome Ag | Methods for the identification of ZAP-70 interacting molecules and for the purification of ZAP-70 |
| MX2009000769A (es) | 2006-07-21 | 2009-01-28 | Novartis Ag | Compuestos de 2,4-di(arilaminio)-pirimidin-5-carboxamida como inhibidores de cinasas jak. |
| JP2010510211A (ja) | 2006-11-16 | 2010-04-02 | ファーマコペイア・リミテッド・ライアビリティ・カンパニー | 免疫抑制用７−置換プリン誘導体 |
| EP2108019A2 (en) * | 2007-01-30 | 2009-10-14 | Biogen Idec MA, Inc. | 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases |
| US7947698B2 (en) | 2007-03-23 | 2011-05-24 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
| WO2008118823A2 (en) | 2007-03-26 | 2008-10-02 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| EP2178563A2 (en) | 2007-07-06 | 2010-04-28 | OSI Pharmaceuticals, Inc. | Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mtorc2 |
| UY31631A1 (es) * | 2008-02-06 | 2009-09-30 | Nuevos derivados de 7-fenil-7h-pirrolo-[2,3d]-pirimidin-2-il-amino, sales de los mismos, procesos para su preparacion, composiciones farmacéuticas que los comprenden y aplicaciones | |
| CL2009001884A1 (es) | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
| US20120040955A1 (en) | 2009-04-14 | 2012-02-16 | Richard John Harrison | Fluoro substituted pyrimidine compounds as jak3 inhibitors |
| US9242987B2 (en) * | 2009-10-20 | 2016-01-26 | Cellzome Limited | Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors |
| US8637529B2 (en) | 2010-06-11 | 2014-01-28 | AbbYie Inc. | Pyrazolo[3,4-d]pyrimidine compounds |
-
2011
- 2011-08-12 US US13/816,555 patent/US9040545B2/en not_active Expired - Fee Related
- 2011-08-12 WO PCT/EP2011/063905 patent/WO2012022681A2/en not_active Ceased
- 2011-08-12 JP JP2013524421A patent/JP2013534233A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013534233A5 (https=) | ||
| JP2013508332A5 (https=) | ||
| JP2014531449A5 (https=) | ||
| RU2014152257A (ru) | Гетероциклильные пиримидиновые аналоги в качестве ингибиторов tyk2 | |
| NZ598907A (en) | Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors | |
| RU2744988C2 (ru) | Соединения и композиции для подавления активности shp2 | |
| SI3083625T1 (en) | Pyrimidopyrimidinones, useful as Wee-1 kinase inhibitors | |
| JP2022501338A5 (https=) | ||
| CA2677572A1 (en) | 3-amino-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives as pkc inhibitors | |
| RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 | |
| RU2013155456A (ru) | Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka | |
| JP2017511365A5 (https=) | ||
| RU2018120330A (ru) | Химерные соединения, осуществляющие нацеливание для протеолиза, и способы их получения и применения | |
| RU2014124950A (ru) | Производные 2-фениламинопиримидина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2) для лечения болезни паркинсона | |
| AU2017286654A1 (en) | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | |
| IL297481A (en) | Halogenated heteroaryls and other heterocyclic kinase inhibitors, and uses thereof | |
| RU2014151009A (ru) | Пиразолопиримидоновые и пиразолопиридоновые ингибиторы танкиразы | |
| RU2009140469A (ru) | Производные пирролопиримидин-7-она и их применение в качестве фармацевтических средств | |
| RU2015106605A (ru) | Соединения замещенных пиразолонов и способы использования | |
| JP2008510771A5 (https=) | ||
| JP2016517878A5 (https=) | ||
| JP2009519979A5 (https=) | ||
| RU2015112580A (ru) | Ингибиторные соединения | |
| RU2348628C2 (ru) | Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные | |
| HRP20241222T1 (hr) | Makrociklički spojevi kao agonisti sting, te postupci i njihova upotreba |